ŞEKER, N. S. Et Al. 2024. Investigation of MTAP and BAP1 staining loss and P16/CDKN2A deletion in pleural cytology specimens and its role in the diagnosis of mesothelioma. DIAGNOSTIC CYTOPATHOLOGY , vol.52, no.4 , 211-216.

ŞEKER, N. S., TEKİN, E., AK, G., METİNTAŞ, M., METİNTAŞ, S., & DÜNDAR, E., (2024). Investigation of MTAP and BAP1 staining loss and P16/CDKN2A deletion in pleural cytology specimens and its role in the diagnosis of mesothelioma. DIAGNOSTIC CYTOPATHOLOGY , vol.52, no.4, 211-216.

ŞEKER, NAZLI Et Al. "Investigation of MTAP and BAP1 staining loss and P16/CDKN2A deletion in pleural cytology specimens and its role in the diagnosis of mesothelioma," DIAGNOSTIC CYTOPATHOLOGY , vol.52, no.4, 211-216, 2024

ŞEKER, NAZLI S. Et Al. "Investigation of MTAP and BAP1 staining loss and P16/CDKN2A deletion in pleural cytology specimens and its role in the diagnosis of mesothelioma." DIAGNOSTIC CYTOPATHOLOGY , vol.52, no.4, pp.211-216, 2024

ŞEKER, N. S. Et Al. (2024) . "Investigation of MTAP and BAP1 staining loss and P16/CDKN2A deletion in pleural cytology specimens and its role in the diagnosis of mesothelioma." DIAGNOSTIC CYTOPATHOLOGY , vol.52, no.4, pp.211-216.

@article{article, author={NAZLI SENA ŞEKER Et Al. }, title={Investigation of MTAP and BAP1 staining loss and P16/CDKN2A deletion in pleural cytology specimens and its role in the diagnosis of mesothelioma}, journal={DIAGNOSTIC CYTOPATHOLOGY}, year=2024, pages={211-216} }